Hemicrania Continua Responsive to Intravenous Methyl Prednisolone

Authors

  • Sanjay Prakash DM,

    1. From the Department of Neurology, Medical College, Baroda, Gujarat, India (S. Prakash and N. Tandon); Department of Medicine, Medical College, Baroda, Gujarat, India (K.J. Brahmbhatt and N.T. Chawda).
    Search for more papers by this author
  • Krutik J. Brahmbhatt MD,

    1. From the Department of Neurology, Medical College, Baroda, Gujarat, India (S. Prakash and N. Tandon); Department of Medicine, Medical College, Baroda, Gujarat, India (K.J. Brahmbhatt and N.T. Chawda).
    Search for more papers by this author
  • Niraj T. Chawda MD,

    1. From the Department of Neurology, Medical College, Baroda, Gujarat, India (S. Prakash and N. Tandon); Department of Medicine, Medical College, Baroda, Gujarat, India (K.J. Brahmbhatt and N.T. Chawda).
    Search for more papers by this author
  • Nidhhi Tandon MD

    1. From the Department of Neurology, Medical College, Baroda, Gujarat, India (S. Prakash and N. Tandon); Department of Medicine, Medical College, Baroda, Gujarat, India (K.J. Brahmbhatt and N.T. Chawda).
    Search for more papers by this author

  • Conflict of Interest: None

S. Prakash, O-19, Doctor's Quarter, Jail Road, Baroda, Gujarat 390001, India.

Abstract

Hemicrania continua (HC) is a strictly unilateral, continuous primary headache disorder with periodic exacerbations, usually accompanied by cranial autonomic disturbances. Exquisite and persistent effect of indomethacin is a fundamental property of HC. We report 2 patients of HC in which attacks were successfully eliminated by repeated infusion of methyl prednisolone.

Ancillary